Eurazeo’s Europe-China fund – a joint effort with China Investment Corporation (CIC) and BNP Paribas – will come online at the end of this month with an initial EUR400 million ($445 million) in dry powder. It is the France-based GP’s latest milestone in a growing engagement with Asia.
CIC has launched a string of similar vehicles as it steps up its private equity co-investment and direct investment activity, typically working with international financial partners to target China-related...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.